Navigation Links
Mesothelioma Experts Focus on Promising Immunotherapy Drug in New Article, According to Surviving Mesothelioma
Date:12/8/2015

In the wake of the FDA approval of Keytruda (pembrolizumab) for non-small cell lung cancer, researchers in Toronto have released an overview of the drug and its potential for treating other cancers, including mesothelioma. Surviving Mesothelioma has just posted an article on the new report. Click here to read it now.

In October, Keytruda was approved to treat non-small cell lung cancer by targeting cancer cells expressing a protein called PD-1.

In an article in Future Oncology, Drs. Safiya Karim and Natasha Leighl with Toronto's Princess Margaret Cancer Center explore Keytruda's potential for treating other cancers, such as malignant pleural mesothelioma, that express the same protein.

“Pembrolizumab is a PD-1 inhibitor that has shown clinical activity in a variety of solid tumors,” note the researchers.

“Because there are so few viable treatment options for patients with mesothelioma, the mesothelioma community is naturally very excited about the future possibilities for Keytruda. We'll be following news of this drug closely,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor.

To read more about the Canadian report and the results of mesothelioma clinical trials with Keytruda, see Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug, now available on the Surviving Mesothelioma website.

Karim, s and Leighl, N, “Pembrolizumab for the treatment of thoracic malignancies: current landscape and future directions”, December 3, 2015, Future Oncology, Epub ahead of print, http://www.futuremedicine.com/doi/abs/10.2217/fon.15.294

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at http://www.prweb.com/releases/2015/12/prweb13117614.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved


Related medicine news :

1. Mesothelioma Law Firm Baron & Budd Calls Attention to Veterans Suffering from Asbestos-Related Diseases
2. Baron & Budd Supports Encouraging New Development in Mesothelioma Treatment
3. Nanotechnology Shows Potential in Fighting Mesothelioma
4. The Meso Foundation Congratulates Representative Betty McCollum’s Efforts to Advance Mesothelioma Research
5. Mesothelioma Advocate Participates in DoD Cancer Research Peer-Review
6. Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
7. Penn mesothelioma program receives $8 million NCI grant
8. New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma
9. New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma
10. Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug, Reports Surviving Mesothelioma
11. New Mesothelioma Research Website Offers In-Depth Articles About Technology and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... , ... August 11, 2018 , ... ... a Silver Stevie® Award in the Executive of the Year-Business category in The ... premier business awards program. All individuals and organizations worldwide – public and private, ...
(Date:8/9/2018)... (PRWEB) , ... August 09, ... ... quality and outcomes by simplifying medication adherence monitoring with Smart-pill bottle and ... DoseSmart® FHIR in the App Orchard. , The DoseSmart medication management and ...
(Date:8/7/2018)... ... August 07, 2018 , ... Sussex Vision Center, a ... Sky Vision. Michael Sussex, OD, founded the practice in Coldwater, and over the last ... Matt Austin, OD, to offer comprehensive eye health services for patients of all ages. ...
(Date:8/3/2018)... ... August 03, 2018 , ... On August 2, 2018 the JPML ordered that ... of Sadaka Associates, LLC has been litigating Zostavax injuries since 2011. ... on Multidistrict Litigation for the thousands of people injured by Zostavax, a vaccine given ...
(Date:8/2/2018)... Pa. (PRWEB) , ... August 02, 2018 , ... ... lifeIMAGE medical image e-sharing platform to connect clinicians inside and outside ... patients suffering a life-threatening stroke or trauma. , AHN joins other leading hospital ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... , ... August 02, 2018 , ... What: The Wharton ... Public Policy Funding, which will allow up to five business reporters who cover aspects ... program in Philadelphia this year. Each funding opportunity covers the cost of tuition, ...
(Date:8/2/2018)... ... 02, 2018 , ... Although there is a wealth of advice out there ... on a generalized “best practices” approach. But now doctors and their patients have a ... health. , Technology exists to help people find the right diet and personalized health ...
(Date:8/2/2018)... ... August 01, 2018 , ... Isagenix International , ... final five finalists in its annual total-body transformation program, the IsaBody Challenge®. They ... of Spartanburg, South Carolina; Christine Manukyan of Glendale, California; and Justin Whelan of ...
Breaking Medicine Technology: